share

1,6-Naphthyridine,3-(Difluoromethoxy)-5,6,7,8-Tetrahydro-(9Ci) CAS NO 705925-03-7


Unit Price:

CAS No.:705925-03-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

1,6-Naphthyridine,3-(Difluoromethoxy)-5,6,7,8-Tetrahydro-(9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant commercial interest for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly within oncology and central nervous system (CNS) drug discovery pipelines.

Application

  • Pharmaceutical Intermediate: Serves as a key synthetic precursor in the research and development of new drug candidates.
  • Organic Synthesis Building Block: Used in complex multi-step organic syntheses to construct sophisticated molecular architectures.
  • Medicinal Chemistry Research: A valuable scaffold for structure-activity relationship (SAR) studies in drug discovery programs.
  • Chemical Reference Standard: Employed as an analytical standard for quality control and method development in pharmaceutical analysis.
  • Agrochemical Research: Potential application as an intermediate in the development of novel crop protection agents.
  • Material Science: Investigated for use in the synthesis of specialty chemicals and functional materials.

Basic Information

Product Name 1,6-Naphthyridine,3-(Difluoromethoxy)-5,6,7,8-Tetrahydro-(9Ci)
CAS No. 705925-03-7
Molecular Formula C10H10F2N2O
Molecular Weight 212.20 g/mol
Synonyms 3-(Difluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridine; 5,6,7,8-Tetrahydro-3-(difluoromethoxy)-1,6-naphthyridine; 1,6-Naphthyridine, 3-(difluoromethoxy)-5,6,7,8-tetrahydro-; 705925-03-7; 3-Difluoromethoxy-5,6,7,8-tetrahydro-1,6-naphthyridine
EINECS Contact for details

Quality Control

Our 1,6-Naphthyridine,3-(Difluoromethoxy)-5,6,7,8-Tetrahydro-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to maintain optimal stability.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%
Single Unknown Impurity (HPLC) ≤ 1.0%
Total Impurities (HPLC) ≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.